CASC15: A Tumor-Associated Long Non-Coding RNA

Author(s): Bei Wang, Wen Xu, Yuxuan Cai, Chong Guo, Gang Zhou, Chengfu Yuan*

Journal Name: Current Pharmaceutical Design

Volume 27 , Issue 1 , 2021


Become EABM
Become Reviewer
Call for Editor

Abstract:

Background: CASC15, one of long non-coding RNA, is involved in the regulation of many tumor biological processes, and is expected to become a new biological therapeutic target. This paper aims to elucidate the pathophysiological function of CASC15 in various tumors.

Methods: The relationship between CASC15 and tumors was analyzed by searching references, and summarized the specific pathophysiological mechanism of CASC15.

Results: LncRNA CASC15 is closely related to tumor development, and has been shown to be abnormally high expressed in all kinds of tumors, including breast cancer, cervical cancer, lung cancer, hepatocellular carcinoma, gastric cancer, bladder cancer, colon cancer, colorectal cancer, cardiac hypertrophy, intrahepatic cholangiocarcinoma, leukemia, melanoma, tongue squamous cell carcinoma and nasopharyngeal carcinoma. However, CASC15 has been found to be down-expressed abnormally in ovarian cancer, glioma and neuroblastoma. Besides, it is identified that CASC15 can affect the proliferation, invasion and apoptosis of tumors.

Conclusion: LncRNA CASC15 has the potential to become a new therapeutic target or marker for a variety of tumors.

Keywords: Long non-coding RNA, CASC15, malignancy, biomarker, molecular mechanism, therapeutic target.

Rights & PermissionsPrintExport Cite as

Article Details

VOLUME: 27
ISSUE: 1
Year: 2021
Published on: 22 September, 2020
Page: [127 - 134]
Pages: 8
DOI: 10.2174/1381612826666200922153701
Price: $65

Article Metrics

PDF: 32